GlassScriptPhysician profile
Natalie A Narrow
NPI 1508231150
$1,945.85
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $959 · 2022: $971 · 2024: $15.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $383.55 | 2021-2022 | |
| Bausch Health US, LLC | $232.88 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $178.98 | 2021-2022 | |
| Aspira Women'S Health INC | $129.84 | 2022 | |
| Therapeuticsmd, INC. | $123.71 | 2021-2022 | |
| Daiichi Sankyo INC. | $120.05 | 2021-2022 | |
| Agile Therapeutics, INC. | $79.30 | 2021-2022 | |
| Scynexis, INC. | $75.93 | 2022 | |
| Novo Nordisk INC | $66.46 | 2021-2022 | |
| Evofem Biosciences, INC. | $66.14 | 2021-2022 | |
| Myovant Sciences INC. | $62.01 | 2021 | |
| Pfizer INC. | $59.97 | 2021-2022 | |
| Exeltis, USA INC. | $58.28 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $53.17 | 2022 | |
| Virtus Pharmaceuticals LLC | $51.01 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $38.67 | 2021 | |
| Avion Pharmaceuticals | $35.93 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $32.65 | 2022 | |
| Coopersurgical, INC. | $25.50 | 2021-2022 | |
| Medtronic, INC. | $15.98 | 2024 | Truclear |
| Merck Sharp & Dohme LLC | $15.97 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.80 | 2021 | |
| Ascend Therapeutics US, LLC | $13.31 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Narrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.